blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3245199

EP3245199 - SUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS USEFUL IN THE TREATMENT OF RESPIRATORY DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  06.11.2020
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  05.12.2019
FormerGrant of patent is intended
Status updated on  06.09.2019
FormerExamination is in progress
Status updated on  05.08.2019
FormerGrant of patent is intended
Status updated on  29.07.2019
FormerExamination is in progress
Status updated on  20.07.2018
FormerRequest for examination was made
Status updated on  20.10.2017
FormerThe international publication has been made
Status updated on  02.08.2017
Most recent event   Tooltip08.07.2022Lapse of the patent in a contracting state
New state(s): MK		published on 10.08.2022  [2022/32]
Applicant(s)For all designated states
Boehringer Ingelheim International GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2017/47]
Inventor(s)01 / HECKEL, Armin
Boehringer Ingelheim GmbH
Corp. Div. Patents
Binger Str. 173
55216 Ingelheim Am Rhein / DE
02 / HAMPRECHT, Dieter
Boehringer Ingelheim GmbH
Corp. Div. Patents
Binger Str. 173
55216 Ingelheim Am Rhein / DE
03 / KLEY, Joerg
Boehringer Ingelheim GmbH
Corp. Div. Patents
Binger Str. 173
55216 Ingelheim Am Rhein / DE
 [2017/47]
Representative(s)Simon, Elke Anna Maria
Boehringer Ingelheim GmbH
Binger Strasse 173
55216 Ingelheim am Rhein / DE
[2017/47]
Application number, filing date16700073.607.01.2016
[2017/47]
WO2016EP50167
Priority number, dateEP2015015082612.01.2015         Original published format: EP 15150826
[2017/47]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016113167
Date:21.07.2016
Language:EN
[2016/29]
Type: A1 Application with search report 
No.:EP3245199
Date:22.11.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 21.07.2016 takes the place of the publication of the European patent application.
[2017/47]
Type: B1 Patent specification 
No.:EP3245199
Date:01.01.2020
Language:EN
[2020/01]
Search report(s)International search report - published on:EP21.07.2016
ClassificationIPC:C07D403/12, C07D401/14, C07D405/14, C07F9/53, C07D403/14, C07F9/141, A61P11/00, A61K31/497, A61K31/662
[2017/47]
CPC:
C07D403/12 (EP,US); A61P11/00 (EP,US); C07D401/14 (EP,US);
C07D403/14 (EP,US); C07D405/14 (EP,US); C07D413/14 (EP,US);
C07F7/1804 (EP,US); C07F9/5304 (EP,US); C07F9/65583 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/47]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:SUBSTITUIERTE BENZIMIDAZOLIUMDERIVATE ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN[2017/47]
English:SUBSTITUTED BENZIMIDAZOLIUM COMPOUNDS USEFUL IN THE TREATMENT OF RESPIRATORY DISEASES[2017/47]
French:COMPOSÉS DE BENZIMIDAZOLIUM SUBSTITUÉS UTILES POUR LE TRAITEMENT DE MALADIES RESPIRATOIRES[2019/33]
Former [2017/47]COMPOSÉS SUBTITUÉS À BASE DE BENZIMIDAZOLIUM UTILISABLES DANS LE TRAITEMENT DE MALADIES RESPIRATOIRES
Entry into regional phase14.08.2017National basic fee paid 
14.08.2017Designation fee(s) paid 
14.08.2017Examination fee paid 
Examination procedure02.08.2017Date on which the examining division has become responsible
14.08.2017Examination requested  [2017/47]
06.03.2018Amendment by applicant (claims and/or description)
20.07.2018Despatch of a communication from the examining division (Time limit: M06)
13.12.2018Reply to a communication from the examining division
22.01.2019Despatch of a communication from the examining division (Time limit: M06)
27.06.2019Reply to a communication from the examining division
30.07.2019Communication of intention to grant the patent
20.11.2019Fee for grant paid
20.11.2019Fee for publishing/printing paid
20.11.2019Receipt of the translation of the claim(s)
Opposition(s)02.10.2020No opposition filed within time limit [2020/50]
Fees paidRenewal fee
31.01.2018Renewal fee patent year 03
31.01.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU07.01.2016
AL01.01.2020
AT01.01.2020
CY01.01.2020
CZ01.01.2020
DK01.01.2020
EE01.01.2020
ES01.01.2020
FI01.01.2020
HR01.01.2020
IT01.01.2020
LT01.01.2020
LV01.01.2020
MC01.01.2020
MK01.01.2020
MT01.01.2020
NL01.01.2020
PL01.01.2020
RO01.01.2020
RS01.01.2020
SE01.01.2020
SI01.01.2020
SK01.01.2020
SM01.01.2020
TR01.01.2020
IE07.01.2020
LU07.01.2020
BE31.01.2020
CH31.01.2020
LI31.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
[2022/31]
Former [2022/30]HU07.01.2016
AL01.01.2020
AT01.01.2020
CY01.01.2020
CZ01.01.2020
DK01.01.2020
EE01.01.2020
ES01.01.2020
FI01.01.2020
HR01.01.2020
IT01.01.2020
LT01.01.2020
LV01.01.2020
MC01.01.2020
MT01.01.2020
NL01.01.2020
PL01.01.2020
RO01.01.2020
RS01.01.2020
SE01.01.2020
SI01.01.2020
SK01.01.2020
SM01.01.2020
TR01.01.2020
IE07.01.2020
LU07.01.2020
BE31.01.2020
CH31.01.2020
LI31.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
Former [2022/27]HU07.01.2016
AT01.01.2020
CY01.01.2020
CZ01.01.2020
DK01.01.2020
EE01.01.2020
ES01.01.2020
FI01.01.2020
HR01.01.2020
IT01.01.2020
LT01.01.2020
LV01.01.2020
MC01.01.2020
MT01.01.2020
NL01.01.2020
PL01.01.2020
RO01.01.2020
RS01.01.2020
SE01.01.2020
SI01.01.2020
SK01.01.2020
SM01.01.2020
TR01.01.2020
IE07.01.2020
LU07.01.2020
BE31.01.2020
CH31.01.2020
LI31.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
Former [2021/10]AT01.01.2020
CZ01.01.2020
DK01.01.2020
EE01.01.2020
ES01.01.2020
FI01.01.2020
HR01.01.2020
IT01.01.2020
LT01.01.2020
LV01.01.2020
MC01.01.2020
NL01.01.2020
PL01.01.2020
RO01.01.2020
RS01.01.2020
SE01.01.2020
SI01.01.2020
SK01.01.2020
SM01.01.2020
IE07.01.2020
LU07.01.2020
BE31.01.2020
CH31.01.2020
LI31.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
Former [2021/08]CZ01.01.2020
DK01.01.2020
EE01.01.2020
ES01.01.2020
FI01.01.2020
HR01.01.2020
LT01.01.2020
LV01.01.2020
MC01.01.2020
NL01.01.2020
RO01.01.2020
RS01.01.2020
SE01.01.2020
SK01.01.2020
SM01.01.2020
IE07.01.2020
LU07.01.2020
BE31.01.2020
CH31.01.2020
LI31.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
Former [2020/51]CZ01.01.2020
DK01.01.2020
EE01.01.2020
ES01.01.2020
FI01.01.2020
HR01.01.2020
LT01.01.2020
LV01.01.2020
MC01.01.2020
NL01.01.2020
RO01.01.2020
RS01.01.2020
SE01.01.2020
SK01.01.2020
SM01.01.2020
LU07.01.2020
BE31.01.2020
CH31.01.2020
LI31.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
Former [2020/50]CZ01.01.2020
DK01.01.2020
EE01.01.2020
ES01.01.2020
FI01.01.2020
HR01.01.2020
LT01.01.2020
LV01.01.2020
MC01.01.2020
NL01.01.2020
RO01.01.2020
RS01.01.2020
SE01.01.2020
SK01.01.2020
SM01.01.2020
LU07.01.2020
BE31.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
Former [2020/49]CZ01.01.2020
DK01.01.2020
ES01.01.2020
FI01.01.2020
HR01.01.2020
LT01.01.2020
LV01.01.2020
MC01.01.2020
NL01.01.2020
RO01.01.2020
RS01.01.2020
SE01.01.2020
SK01.01.2020
SM01.01.2020
LU07.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
Former [2020/48]CZ01.01.2020
DK01.01.2020
ES01.01.2020
FI01.01.2020
HR01.01.2020
LT01.01.2020
LV01.01.2020
NL01.01.2020
RO01.01.2020
RS01.01.2020
SE01.01.2020
SM01.01.2020
LU07.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
Former [2020/47]CZ01.01.2020
DK01.01.2020
ES01.01.2020
FI01.01.2020
HR01.01.2020
LT01.01.2020
LV01.01.2020
NL01.01.2020
RS01.01.2020
SE01.01.2020
LU07.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
Former [2020/46]CZ01.01.2020
FI01.01.2020
HR01.01.2020
LT01.01.2020
LV01.01.2020
NL01.01.2020
RS01.01.2020
SE01.01.2020
LU07.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
Former [2020/40]CZ01.01.2020
FI01.01.2020
HR01.01.2020
LT01.01.2020
LV01.01.2020
NL01.01.2020
RS01.01.2020
SE01.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
IS01.05.2020
PT27.05.2020
Former [2020/39]CZ01.01.2020
FI01.01.2020
HR01.01.2020
LT01.01.2020
LV01.01.2020
NL01.01.2020
RS01.01.2020
SE01.01.2020
BG01.04.2020
NO01.04.2020
GR02.04.2020
PT27.05.2020
Former [2020/38]CZ01.01.2020
FI01.01.2020
HR01.01.2020
LT01.01.2020
LV01.01.2020
NL01.01.2020
RS01.01.2020
SE01.01.2020
NO01.04.2020
GR02.04.2020
PT27.05.2020
Former [2020/37]CZ01.01.2020
FI01.01.2020
HR01.01.2020
LT01.01.2020
LV01.01.2020
NL01.01.2020
RS01.01.2020
SE01.01.2020
NO01.04.2020
PT27.05.2020
Former [2020/36]CZ01.01.2020
FI01.01.2020
LT01.01.2020
NL01.01.2020
RS01.01.2020
NO01.04.2020
PT27.05.2020
Former [2020/35]CZ01.01.2020
FI01.01.2020
LT01.01.2020
NL01.01.2020
NO01.04.2020
Former [2020/33]NL01.01.2020
Cited inInternational search[YD]WO2011079087  (GLAXO GROUP LTD [GB], et al) [YD] 1-13 * claims 1, 3, 4; compounds 29, 33, 60, 66, 86 *;
 [XP]WO2015007516  (BOEHRINGER INGELHEIM INT [DE]) [XP] 1,6-13* claims 1, 10-14 *;
 [Y]  - SCHOENBERGER M ET AL, "Novel small molecule epithelial sodium channel inhibitors as potential therapeutics in cystic fibrosis - a patent evaluation", EXPERT OPINION ON THERAPEUTIC PATENTS, INFORMA HEALTHCARE, GB, vol. 23, no. 10, doi:10.1517/13543776.2013.829454, ISSN 1354-3776, (20131001), pages 1383 - 1389, (20130819), XP002720993 [Y] 1-13 * paragraph [0004]; figure 2 *

DOI:   http://dx.doi.org/10.1517/13543776.2013.829454
 [AD]  - ERTL P ET AL, "FAST CALCULATION OF MOLECULAR POLAR SURFACE AREA AS A SUM FRAGMENT-BASED CONTRIBUTIONS AND ITS APPLICATION TO THE PREDICTION OF DRUG TRANSPORT PROPERTIES", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (20000101), vol. 43, no. 20, doi:10.1021/JM000942E, ISSN 0022-2623, pages 3714 - 3717, XP002942715 [AD] 1-13 * table 3 *

DOI:   http://dx.doi.org/10.1021/jm000942e
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.